You are here: Industry Insights > IDMA

News List

Achieving Aatmanirbharta in APIs: Are we on the right track? expresspharma
August 03, 2021
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats.
IDMA supports patent waiver for vaccines to ramp up production expresspharma
May 14, 2021
Urges global pharma companies to grant voluntary licenses (VL) and transfer technology of vaccines to Indian companies against reasonable royalties.
Industry welcomes PLI 2.0 Scheme, awaits implementation details expresspharma
February 26, 2021
Stakeholders highlight that this scheme will help play to our strengths, work towards making the pharma industry more self-reliant, generate employment and usher more affordability in healthcare.
DCGI calls for suggestions from industry to reduce compliance burden expresspharma
January 29, 2021
The Drug Controller General of India (DCGI) has asked industry associations to submit their representations highlighting aspects or issues in the Drug and Cosmetics Rule 1945 that can be made redundant to reduce the compliance burden on the industry.
Include pharma workforce in priority list for COVID-19 vaccination: Pharma associations expresspharma
January 07, 2021
The proposed move will benefit over two million workforce and ensure uninterrupted supply of medicines in the country, say associations.
DoP organises meeting with industry associations to discuss implementation of Phase II PLI scheme expresspharma
November 23, 2020
Reportedly, industry associations have jointly submitted their suggestions to the department.
Pharma industry requests government to delay release of new NLEM list expresspharma
August 18, 2020
Industry stakeholders also presented issues related to the NLEM list 2015 and suggested course corrective measures in the upcoming NLEM list.
No shortage of APIs and formulations in the country, says Government expresspharma
March 17, 2020
The National Pharmaceutical Pricing Authority (NPPA) has been assured by pharma industry body Indian Drugs Manufacturing Association (IDMA) ...
Indian pharma industry lauds MoEFCC move expresspharma
March 17, 2020
The recent move by the Government of India, along with the Department of Pharmaceuticals (DoP), Niti Aayog and the Ministry of Environment.
IDMA Marketing and Sales Conference 2017 held in Mumbai expressbpd
November 27, 2017
Vinay Pinto, Chairman, Marketing Committee- IDMA and Executive Director, Wallace Pharmaceutical, welcomed the delegates and gave a brief introduction about the day-long conference.

Previous page 1 2 Next page